Scarica l'app Stockscreener
1.32
3.13%
0.04
Dopo l'orario di chiusura:
1.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUMA Giù?
Forum
Previsione
Precedente Chiudi:
$1.28
Aprire:
$1.27
Volume 24 ore:
3.06M
Relative Volume:
0.60
Capitalizzazione di mercato:
$247.20M
Reddito:
-
Utile/perdita netta:
$-110.78M
Rapporto P/E:
-1.2336
EPS:
-1.07
Flusso di cassa netto:
$-75.59M
1 W Prestazione:
+10.00%
1M Prestazione:
-22.81%
6M Prestazione:
-47.83%
1 anno Prestazione:
-69.16%
Intervallo 1D:
$1.24
$1.32
Intervallo di 1 settimana:
$1.09
$1.32
Portata 52W:
$1.09
$6.77
Humacyte Inc Stock (HUMA) Company Profile
Nome
Humacyte Inc
Settore
Industria
Telefono
919-313-9633
Indirizzo
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Confronta HUMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.32 | 239.71M | 0 | -110.78M | -75.59M | -1.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-27 | Iniziato | Barclays | Overweight |
| 2025-05-14 | Ripresa | H.C. Wainwright | Buy |
| 2024-12-20 | Reiterato | H.C. Wainwright | Buy |
| 2023-12-11 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-14 | Aggiornamento | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-05-16 | Downgrade | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | Iniziato | Cowen | Outperform |
| 2021-09-24 | Iniziato | Oppenheimer | Outperform |
| 2021-09-22 | Iniziato | BTIG Research | Buy |
| 2021-09-16 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Humacyte Inc Borsa (HUMA) Ultime notizie
Humacyte’s Major Breakthroughs Impress Investors: Market Reactions - StocksToTrade
Humacyte Inc. (HUMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
D. Boral Capital Maintains Humacyte (HUMA) Buy Recommendation - MSN
Humacyte (HUMAW) Stock Price, News & Analysis - MarketBeat
Humacyte, Inc. (HUMA) stock price, news, quote and history - Yahoo Finance UK
Quantitative breakdown of Humacyte Inc. recent moveMarket Movers & Long-Term Growth Plans - newser.com
Humacyte releases press info on VEITH symposium presentation - Traders Union
D. Boral Capital Reiterates "Buy" Rating for Humacyte (HUMA) | H - GuruFocus
Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results - The Manila Times
Humacyte (Nasdaq: HUMA) Details ATEV Recellularization and 2-Year Trauma Data - Stock Titan
What recovery options are there for Humacyte Inc. Equity WarrantWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Real time pattern detection on Humacyte Inc. stockPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Will Humacyte Inc. Equity Warrant stock see insider buyingDividend Hike & Real-Time Stock Movement Alerts - newser.com
Will Humacyte Inc. see short term momentumJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Will Humacyte Inc. stock deliver shareholder valueJuly 2025 Summary & Risk Controlled Daily Plans - newser.com
Is Humacyte Inc. stock supported by strong cash flows2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
How to interpret RSI for Humacyte Inc. stock2025 Valuation Update & Precise Buy Zone Identification - newser.com
Multi asset correlation models including Humacyte Inc. Equity WarrantWeekly Trade Review & Verified Short-Term Plans - newser.com
Is Humacyte Inc. Equity Warrant stock ready for a breakoutInsider Selling & Real-Time Price Movement Reports - newser.com
Is Humacyte Inc. Equity Warrant stock attractive for retirement portfolios - newser.com
Is Humacyte Inc. Equity Warrant stock attractive for growth ETFsQuarterly Trade Review & Daily Risk Controlled Trade Plans - newser.com
Will Humacyte Inc. stock benefit from infrastructure spendingEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Using RSI to spot recovery in Humacyte Inc. Equity Warrant2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
Humacyte Inc: Is It a Time of Strategic Shift? - StocksToTrade
[Form 4] Humacyte, Inc. Insider Trading Activity - Stock Titan
Humacyte introduces Symvess at Veith Symposium - Traders Union
Technical analysis overview for Humacyte Inc. Equity Warrant stockJuly 2025 Opening Moves & Detailed Earnings Play Strategies - newser.com
Earnings visualization tools for Humacyte Inc.Market Rally & Weekly Stock Performance Updates - newser.com
Chart overlay techniques for tracking Humacyte Inc.2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Can Humacyte Inc. stock reach $100 price targetJuly 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com
Key metrics from Humacyte Inc.’s quarterly dataQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
Should I hold or sell Humacyte Inc. Equity Warrant stock in 2025Chart Signals & Verified Short-Term Plans - newser.com
Will Humacyte Inc. stock attract more institutional investorsLong Setup & Weekly Return Optimization Plans - newser.com
Is Humacyte Inc. stock trading near support levels2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com
What analysts say about Humacyte Inc Equity Warrant stockMarket Breadth Indicators & Outstanding Capital Returns - earlytimes.in
Is Humacyte Inc. stock cheap compared to fundamentalsJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
Humacyte Inc Azioni (HUMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.53%
1.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):